In the DANMAP 2000 report, higher levels of resistance in travel-associated Salmonella and Campylobacter infections were reported for the first time (29).
DANMAP systematically reports these data in conjunction with resistance data, which has enabled identification of specific problems linked to antimicrobial consumption for human therapy (Table).
Increasing use of antimicrobial agents by humans, both outside and inside hospitals, was reported by DANMAP in 2000 (29).
Unlike the monitoring programs in Sweden and Norway, DANMAP never included bacteria obtained from companion animals (5,6), and rational therapy guidelines for companion animals have not been promoted or implemented in veterinary university clinics or private veterinary practices.
In future DANMAP reports, more attention should be given to the presence of extended-spectrum [beta]-lactamase (ESBL)--producing E.
DANMAP has led to changes in the use of antimicrobial agents in Denmark and other countries.
This work was part of DANMAP and was funded by the Danish Ministry of Family and Consumer Affairs and the Danish Ministry of the Interior and Health.
Throughout the 11-year old period under review, Dr Hammerum has been working with surveillance and research related to the DANMAP program (the first 5 years at National Food Institute, Technical University of Denmark, and the next 6 at SSI).
DANMAP 2005--antibiotic consumption and resistance.
DANMAP 2004--consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark.
DANMAP 98--consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark.